Javascript must be enabled to continue!
Summary of German‐Austrian HIV PrEP guideline
View through CrossRef
ObjectivesHIV Pre‐Exposure prophylaxis (PrEP) is a strategy to reduce HIV transmission in people at risk. Aim of this first German‐Austrian PrEP guideline is to provide professional guidance on: when and in whom to use PrEP, recommended laboratory tests before and while on PrEP, selection of drugs, prevention of adverse events as a consequence of missing accompanying medical care, and general handling of PrEP in adults and adolescents.MethodsCommented summary of of the S2k PrEP consensus guidelines released by the German and Austrian HIV medical societies to highlight the key recommendations of the guidelines.ContentDetailed information about effectiveness of PrEP, when and in whom to use PrEP, as well as about additional monitoring of HIV PrEP are included in the HIV PrEP guidelines. Therewith detailed guidance for people being involved in PrEP counseling and associated care is provided.
Title: Summary of German‐Austrian HIV PrEP guideline
Description:
ObjectivesHIV Pre‐Exposure prophylaxis (PrEP) is a strategy to reduce HIV transmission in people at risk.
Aim of this first German‐Austrian PrEP guideline is to provide professional guidance on: when and in whom to use PrEP, recommended laboratory tests before and while on PrEP, selection of drugs, prevention of adverse events as a consequence of missing accompanying medical care, and general handling of PrEP in adults and adolescents.
MethodsCommented summary of of the S2k PrEP consensus guidelines released by the German and Austrian HIV medical societies to highlight the key recommendations of the guidelines.
ContentDetailed information about effectiveness of PrEP, when and in whom to use PrEP, as well as about additional monitoring of HIV PrEP are included in the HIV PrEP guidelines.
Therewith detailed guidance for people being involved in PrEP counseling and associated care is provided.
Related Results
1270. Population-Based Estimates of PrEP Access in Oregon, 2012–2016
1270. Population-Based Estimates of PrEP Access in Oregon, 2012–2016
Abstract
Background
PrEP is an important HIV prevention modality. Population-based metrics of PrEP uptake and access are critica...
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
A infecção pelo vírus do HIV pode ocorrer de diversas maneiras, tendo sua principal forma a via sexual por meio do sexo desprotegido. O vírus do HIV fica em um período de incubação...
Oral Pre-Exposure Prophylaxis (PrEP) Awareness and Acceptability Among Persons who Inject Drugs (PWID) in Kenya: A Qualitative Investigation
Oral Pre-Exposure Prophylaxis (PrEP) Awareness and Acceptability Among Persons who Inject Drugs (PWID) in Kenya: A Qualitative Investigation
AbstractBackground:People who inject drugs (PWID) are disproportionately affected by HIV despite the availability of multiple efficacious biomedical prevention interventions includ...
Improving awareness and uptake of pre-exposure HIV prophylaxis amongst service users accessing Sexual Health London, a regional online postal sexually transmitted infection testing health service
Improving awareness and uptake of pre-exposure HIV prophylaxis amongst service users accessing Sexual Health London, a regional online postal sexually transmitted infection testing health service
Background The UK pledged commitment to the global strategy of zero new HIV infections and HIV-related deaths by 2030. PrEP was commissioned in England in 2020 and is fundamental t...
Profilaxia pré-exposição ao HIV no SUS: estágio atual e dimensionamento das iniciativas estaduais de prescrição farmacêutica
Profilaxia pré-exposição ao HIV no SUS: estágio atual e dimensionamento das iniciativas estaduais de prescrição farmacêutica
Introdução: A profilaxia Pré-exposição ao HIV (PrEP), com o uso dos antirretrovirais Tenofovir/Entricitabina (TDF/FTC), é fornecida pelo Sistema Único de Saúde (SUS), para pessoa c...
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Background: HIV rapid diagnosis in The Gambia is mainly done using Determine HIV-1/2 and First Response HIV 1.2.0 or SD Bioline HIV-1/2 3.0 for screening and sero-typing of HIV res...
Impact of HIV/AIDS scale-up on non-HIV priority services in Nyanza Province, Kenya
Impact of HIV/AIDS scale-up on non-HIV priority services in Nyanza Province, Kenya
Background: The HIV pandemic has attracted unprecedented scale-up in resources to curb its escalation and manage those afflicted. Although evidence from developing countries sugges...
ADESÃO AO USO DA PrEP (PROFILAXIA PRÉ-EXPOSIÇÃO) COMO MEDIDA DE PREVENÇÃO AO HIV
ADESÃO AO USO DA PrEP (PROFILAXIA PRÉ-EXPOSIÇÃO) COMO MEDIDA DE PREVENÇÃO AO HIV
A adesão à Profilaxia Pré-Exposição (PrEP) é fundamental na prevenção do HIV, especialmente entre populações vulneráveis. A eficácia dessa intervenção depende da consistência e cor...

